Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone–releasing hormone analogues AN-152 and AN-207

This publication has 31 references indexed in Scilit:

• Cancer Statistics, 2003
  CA: A Cancer Journal for Clinicians, 2003
• Fertility‐preserving treatment in young patients with endometrial adenocarcinoma
  Cancer, 2002
• HIGH INCIDENCE OF RECEPTORS FOR LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) AND LHRH RECEPTOR GENE EXPRESSION IN HUMAN PROSTATE CANCERS
  Journal of Urology, 2000
• Endometrial cancer
  Current Opinion in Oncology, 1999
• Presence of Gonadotropin-Releasing Hormone Receptor and Its Messenger Ribonucleic Acid in Endometrial Carcinoma and Endometrium
  Gynecologic Oncology, 1994
• Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75
  Regulatory Peptides, 1993
• Characteristics and distribution of receptors for [d‐trp⁶]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
  Journal of Clinical Laboratory Analysis, 1989
• Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients
  Gynecologic Oncology, 1984
• Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture
  In Vitro Cellular & Developmental Biology - Plant, 1983
• LIGAND: A versatile computerized approach for characterization of ligand-binding systems
  Analytical Biochemistry, 1980